ARX
ANALYST NOTE: ARX (Accelerant Holdings) Date: 2026-06-13
1. Structural Readiness
Current State: Forming
- Current Price: $12.99
- Aggressive Entry (Pre-Breakout): $15.31
- Conservative Entry: — (Not yet actionable; requires confirmed breakout)
- Breakout Level: $31.18 (Resistance level that must be cleared to confirm the setup)
- Extension: —
- Volatility Context: Current ATR is 6.8% (Very High). This indicates elevated intraday volatility, which impacts position sizing but does not alter the structural definition of the coil.
2. Thesis Layer
Thesis Status: TACTICAL / Setup-Led Macro Context: There is no named secular thesis attached to this name as of 2026-06-13. The investment case is not driven by a specific macro theme (e.g., "AI in Insurance" or "Rate Cut Cycle") but is strictly setup-led. Judgment Criteria: Conviction must be derived entirely from the quality of the technical structure (the forming coil) and the underlying business fundamentals (EBITDA growth, margin expansion, and capital efficiency). Do not invent a macro narrative to justify the position.
3. Business Fundamentals
Company Overview: Accelerant Holdings operates a specialized, data-driven risk exchange that connects specialty insurance underwriters (Members/MGAs) with Risk Capital Partners. The company operates across the United States, Europe, Canada, and the United Kingdom. Business Model: The platform generates revenue through three primary segments:
- Exchange Services: Fees for connecting underwriters with capital.
- MGA Operations: Fees earned from originating and underwriting portfolios.
- Underwriting: Direct underwriting of policies and assumption of reinsurance (including the Flywheel Re sidecar).
Key Operational Metrics (as of Q1/Q2 2026):
- Premium Growth: Exchange Written Premium grew 35% year-over-year in 2025 to $4.19 billion. For Q2 2026, management expects exchange written premium of $1.27B–$1.32B and third-party direct written premium of $580M–$620M.
- Pipeline Strength: As of Q1 2026, the company held over $4 billion of annualized premium in its member pipeline.
- Member Expansion: The network grew to 296 member MGAs in Q1 2026, adding 16 new members. These members are typically experienced MGAs with $10–$40 million in premium and 15 years of tenure.
- Capital Efficiency & Margins: Management expects adjusted EBITDA margins of approximately 70% for the remainder of 2026. Full-year 2026 adjusted EBITDA is guided to be at least $285 million.
- Strategic Shift (Hadron): The company is actively reducing reliance on its affiliate, Hadron. Hadron's gross written premiums were 41% of third-party premiums in Q1 2026, down from 67% in Q1 2025. Management expects this mix to further decline to 35–40% for the full year 2026.
- Balance Sheet & Capital:
- LPT: Effective Jan 2026, a Loss Portfolio Transfer (LPT) contract reinsured retained loss reserves for policies written July 2022–June 2024 (limit $151.4M).
- Investment Exit: In April 2026, the company sold ~50% of a third-party claims administration investment, generating $51.6M in cash proceeds and realizing a $54.5M gain.
- Share Buybacks: Between April 1 and May 8, 2026, the company repurchased and retired 3.44 million shares for $46.8M at an average price of $13.60.
4. Archetype and Conviction
Archetype: Quality Compounder Rationale: The business fits the "Quality Compounder" archetype due to its high-margin structure (70% EBITDA margins), strong Net Revenue Retention (126% in 2025), and consistent double-digit growth in written premium. The shift away from the affiliate (Hadron) toward third-party premiums and the expansion of the MGA network suggest a scalable, asset-light model. Valuation Context: The financial spine indicates a forward consensus EPS of $0.74 for FY1 and $0.92 for FY2. Conviction Stack:
- Thesis Strength: Low (Tactical only; no macro tailwinds).
- Evidence Quality: High. Recent earnings (May 14, 2026) and filings (May 13, 2026) provide robust, specific guidance on premiums, margins, and capital deployment.
- Setup Readiness: Partial. The setup is valid but requires a breakout above $31.18 to confirm. The current price ($12.99) is well below the breakout level, suggesting a significant run-up is required for the setup to complete.
- Rerating Potential: Dependent on the successful execution of the "Flywheel" strategy and the continued decoupling from Hadron.
5. Invalidations, Strengths, and Gaps
Invalidation Triggers:
- Fundamental: A significant deviation from the Q2 2026 guidance (e.g., exchange written premium falling below $1.27B) or a failure to maintain the 70% EBITDA margin trajectory.
Strengthening Factors:
- Technical: A confirmed close above $31.18, which would convert the "Forming" coil to a "Confirmed" coil.
- Fundamental: Continued reduction of Hadron mix below 35% and successful onboarding of new MGAs in new geographies (beyond US/UK/EU/Canada).
Evidence Gaps:
- No Missing Evidence: The evidence base is complete as of the event date. All necessary filings, transcripts, and financial data are present.
- Volatility Risk: The "Very High" ATR (6.8%) suggests the stock may experience sharp swings, which could trigger stop-outs before a breakout occurs, even if the fundamental thesis remains intact.
PRIVATE ANALYST CALL
Judgment: Speculative Confidence: medium Key evidence: 1) Management guidance for 70% adjusted EBITDA margins and $285M full-year EBITDA; 2) Strong Net Revenue Retention of 126% and $4B+ member pipeline; 3) Active share buyback program reducing float at $13.60 average. Key risks: 1) Technical setup is "Forming" with a massive breakout gap ($12.99 to $31.18) requiring significant momentum; 2) Very High ATR (6.8%) increases risk of whipsaw volatility; 3) Dependence on successful execution of the Hadron mix-down strategy. Sizing hint: Position size should be reduced relative to a confirmed breakout setup due to the "Forming" state and elevated volatility. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation). Failure mode to watch: A daily close below $12.57, which would invalidate the coil structure and signal a breakdown in support.
Chart
Evidence & Catalysts
Source-backed evidence anchors and catalysts land once Convexity finishes coverage for ARX.
Core Assumptions
Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.
Value Picture
Value picture unavailable — no financial spine on file for ARX.
Financial Highlights
Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.